Document is current
Any future updates will be listed below
-
Authors
Hammerschmidt, Philipp
Steculorum, Sophie M. https://orcid.org/0000-0002-5665-2732
Bandet, Cécile L.
Del Río-Martín, Almudena https://orcid.org/0009-0005-4414-3358
Steuernagel, Lukas https://orcid.org/0000-0003-0043-1436
Kohlhaas, Vivien
Feldmann, Marvin
Varela, Luis
Majcher, Adam
Quatorze Correia, Marta
Klar, Rhena F. U.
Bauder, Corinna A.
Kaya, Ecem
Porniece, Marta https://orcid.org/0000-0003-2330-5846
Biglari, Nasim
Sieben, Anna https://orcid.org/0000-0002-3208-6393
Horvath, Tamas L. https://orcid.org/0000-0002-7522-4602
Hornemann, Thorsten https://orcid.org/0000-0002-4218-1087
Brodesser, Susanne https://orcid.org/0000-0001-5631-0663
Brüning, Jens C. https://orcid.org/0000-0002-6619-0092
- License Information
-
More Information
Article History
Received: 6 August 2021
Accepted: 17 October 2023
First Online: 29 November 2023
Competing interests
: J.C.B. is co-founder of Cerapeutix and has received research funding through collaborations with Sanofi Aventis and Novo Nordisk Inc., which did not affect the content of this article. The remaining authors declare no competing interests.
